Clinical trial
A Randomized, Placebo Controlled, Double-blind, Phase 4 Study to Evaluate Efficacy and Safety of Triple Anti-platelet Therapy Compared With Dual Antiplatelet Therapy in Patients Treated With Drug Eluting Stent for Coronary Artery Disease
NCT01346865 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo Controlled, Double-blind, Phase 4 Study to Evaluate Efficacy and Safety of Triple Anti-platelet Therapy Compared With Dual Antiplatelet Therapy in Patients Treated With Drug Eluting Stent for Coronary Artery Disease
- Lead sponsor
- Seung-Jung Park
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- May 31, 2011
- Completion date
- February 28, 2015
- Enrollment
- 402 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.